Skip to content

PANDA PLUS

Active Private limited companyfounded 2021active for 5 yearsEredienststraat 10, 1000 BrusselsKBO/BCE: BE 0764.405.332

Lifetime

4 annual accounts with figures on one time axis
peak of €77,287 in 2022
€10,322▼ 64.0%
lowest -€13,658 in 2023
€9,391▲ €23,049
peak of €36,729 in 2022
€32,313▲ 41.0%
€45,471▲ 12×
Board1 name since 2024
1 director
Documentsfilings and deeds
23-10-202584 days late
2024micro format
Gross margin from €28,638 to €10,322Profit of €9,391, after a lossCompany renamed from TODAYPHARMA to PANDA PLUS 27-03Equity from €22,922 to €32,313Debts from €3,873 to €45,471

Key points

from the 2024 annual accounts

Investments

€19,963 44.8 times depreciation
20212024

Green is investment, beige is depreciation.

Liquidity

1.28 was 6.92 in 2023

Short-term debts rose from €3,873 to €45,471.

Filings

4 annual accounts 114 days past the deadline
AprilJune31 JulyOctober2021202220232024

2025 accounts not filed: deadline was 31-07-2026.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as PANDA PLUS has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for PANDA PLUS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 60 sharesdeed of 27-03-2024
  • 60 sharesdeed of 27-03-2024
  • 20 sharesdeed of 27-03-2024
and 2 other shareholdersBoard & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0764405332
Company renamed from TODAYPHARMA to PANDA PLUS Transfer of 100 shares to · (director) and (director) resign · appointed as director · General meeting of 25-03-2024 · Gazette deed
Incorporation Founding capital of €20,000, 100 shares · Founded by , , and 1 other · (director) and (director) appointed · published on 02-03-2021 · Gazette deed
First establishment TODAYPHARMA, Eredienststraat 10, Brussels
All 12 events

Comparable companies

same main activity, similar in size and age
Company
PANDA PLUS Brussels €77,784 €10,322 41.5% -
WARDANI Ganshoren €79,976 €12,574 53.9% -
Prometheus HealthCare Incourt €64,621 €11,987 23.6% -
APOTHEKER LAURA SPIRITUS Linter €62,639 €11,797 10.3% -
Farma & zorg Aalst €74,440 €13,024 35.7% -
KEPHAS PHARMA Pont-à-Celles €57,577 €13,925 58.2% -
PHARMELLE Aalst €48,646 €13,408 21.4% -

These companies have the same main activity as PANDA PLUS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €48,600 and €80,000, founded between 2017 and 2022.

Official details

Source: KBO
Status
Active since 26-02-2021Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 1 other
Establishment unit
2.326.680.0081000 Brussels, since 26-02-2021
Financial year end
31 December
Peppol
Reachable since 31-12-2025
Company details

Annual accounts 2024

≈ €110,000estimated
€77,784▲ 190%
Filing
Filed on 23-10-2025
Financials

Insights on PANDA PLUS

PANDA PLUS files the micro format. That format states no turnover. The gross margin fell from €45,497 in 2021 to €10,322 in 2024.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PANDA PLUS

What is the company number of PANDA PLUS?
The company number of PANDA PLUS is 0764.405.332. The VAT number is the same number with BE in front: BE 0764.405.332.
Where is PANDA PLUS based?
The registered office is at Eredienststraat 10, 1000 Brussels.Company details
What does PANDA PLUS do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PANDA PLUS?
PANDA PLUS is a private limited company (BV).
When was PANDA PLUS founded?
PANDA PLUS was founded on 26-02-2021.
Is PANDA PLUS still active?
Yes, PANDA PLUS is an active enterprise in the KBO register.
How many employees does PANDA PLUS have?
PANDA PLUS had an average of 1 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
What is the turnover of PANDA PLUS?
The turnover in financial year 2024 is about €110,000. This figure is estimated from the gross margin of €10,322 and 137 comparable companies (NACE 477). It probably lies between €39,000 and €230,000. It is a rough estimate.
Is PANDA PLUS profitable?
In financial year 2024, PANDA PLUS made a profit of €9,391.
Where can I find the annual accounts of PANDA PLUS?
PANDA PLUS filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
When are the next annual accounts of PANDA PLUS due?
PANDA PLUS had to file the annual accounts for financial year 2025 by 31-07-2026. On 22-11-2026 they are not filed yet, 114 days past the deadline.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.